ARCHIVES

Letter: A Modest Proposal To Abolish FDA

This article is from The Cancer Letter archive.

Vol. 22 No. 04 | January 26, 1996

Download PDF Visit The Full Archive

Related Articles

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

August 28, 2009

Other NCI funding opportunities listed.

July 9, 2004

1998 Cancer Meetings Listed Through Oct.

January 9, 1998

High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer

January 25, 2008

NCAB Votes To ‘Keep Alive’ Concept For Stage 2 Breast Cancer Fat Trial

February 14, 1986

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

July 20, 1990